Decitabine as a treatment choice for de novo acute basophilic leukemia: transient response-a case report

Acute basophilic leukemia (ABL), as a rare form of acute myeloid leukaemia (AML) accounts for <1% of cases of AML. ABL has not been detected for encouragingly specific targets. Here we report a de novo fragile ABL case treated with decitabine based regimen with transient response even if overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lei, Wang, Rong, Wang, Yan, Zhao, Si-Shu, Yang, Hui, Xu, Ji, Long, Qi-Qiang, He, Guang-Sheng, Li, Jian-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798097/
https://www.ncbi.nlm.nih.gov/pubmed/35117474
http://dx.doi.org/10.21037/tcr.2019.12.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798097/
https://www.ncbi.nlm.nih.gov/pubmed/35117474
http://dx.doi.org/10.21037/tcr.2019.12.14

Ejemplares similares